Cargando…

The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial

Irritable bowel syndrome (IBS) is a common disorder in gastrointestinal system and impairs the quality of life of the patients. Clostridium butyricum (CB) is a probiotics that has been used in several gastrointestinal diseases. The efficacy of CB in treating IBS is still unknown. This prospective, m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yi-Yuan, Li, Ming, Li, Yue-Yue, Li, Li-Xiang, Zhai, Wen-Zhe, Wang, Peng, Yang, Xiao-Xiao, Gu, Xiang, Song, Li-Jin, Li, Zhen, Zuo, Xiu-Li, Li, Yan-Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813237/ https://www.ncbi.nlm.nih.gov/pubmed/29445178 http://dx.doi.org/10.1038/s41598-018-21241-z

Ejemplares similares

Clostridium butyricum alleviates intestinal low-grade inflammation in TNBS-induced irritable bowel syndrome in mice by regulating functional status of lamina propria dendritic cells
por: Zhao, Qin, et al.
Publicado: (2019)

Clostridium butyricum Combined with Bifidobacterium infantis Probiotic Mixture Restores Fecal Microbiota and Attenuates Systemic Inflammation in Mice with Antibiotic-Associated Diarrhea
por: Ling, Zongxin, et al.
Publicado: (2015)

Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome
por: Zhuang, Xiaojun, et al.
Publicado: (2018)

Brain Functional Interaction of Acupuncture Effects in Diarrhea-Dominant Irritable Bowel Syndrome
por: Ma, Kai, et al.
Publicado: (2020)

Clinical characteristic and fecal microbiota responses to probiotic or antidepressant in patients with diarrhea-predominant irritable bowel syndrome with depression comorbidity: a pilot study
por: Zhang, Lu, et al.
Publicado: (2019)

Modulation of the Intestinal Microbiota by the Early Intervention with Clostridium Butyricum in Muscovy Ducks
por: Xiao, Xingning, et al.
Publicado: (2021)

Association of Fecal Microbiota with Irritable Bowel Syndrome-Diarrhea and Effect of Traditional Chinese Medicine for Its Management
por: Yang, Fang, et al.
Publicado: (2021)

Optimization of an economical medium composition for the coculture of Clostridium butyricum and Bacillus coagulans
por: Li, Yonghong, et al.
Publicado: (2022)

Fecal Microbiota Transplantation Combined with a Low FODMAP Diet for the Treatment of Irritable Bowel Syndrome with Predominant Diarrhea
por: Huang, Hong-Li, et al.
Publicado: (2022)

Efficacy of Chinese Herbal Medicine for Diarrhea-Predominant Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
por: Zhu, Jia-Jie, et al.
Publicado: (2016)

Therapeutic potential of Clostridium butyricum anticancer effects in colorectal cancer
por: Xu, Hui, et al.
Publicado: (2023)

Altered profiles of fecal metabolites correlate with visceral hypersensitivity and may contribute to symptom severity of diarrhea-predominant irritable bowel syndrome
por: Zhang, Wen-Xue, et al.
Publicado: (2019)

The effects of Clostridium butyricum on Ira rabbit growth performance, cecal microbiota and plasma metabolome
por: Ye, Xiao Xing, et al.
Publicado: (2022)

Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
por: Cui, Xiufang, et al.
Publicado: (2021)

The Efficacy of Shugan Jianpi Zhixie Therapy for Diarrhea-Predominant Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
por: Xiao, Ya, et al.
Publicado: (2015)

Health benefits of butyrate and its producing bacterium, Clostridium butyricum, on aquatic animals
por: Tran, Ngoc Tuan, et al.
Publicado: (2023)

Aerosol Inhalation of Heat-Killed Clostridium butyricum CGMCC0313-1 Alleviates Allergic Airway Inflammation in Mice
por: Li, Laodong, et al.
Publicado: (2022)

Effects of Clostridium butyricum on growth performance, meat quality, and intestinal health of broilers
por: Li, Zhen, et al.
Publicado: (2023)

Biotechnological potential of Clostridium butyricum bacteria
por: Szymanowska-Powałowska, Daria, et al.
Publicado: (2014)

Effect of Clostridium butyricum on Gastrointestinal Infections
por: Ariyoshi, Tadashi, et al.
Publicado: (2022)

Characterization of kynurenine pathway in patients with diarrhea-predominant irritable bowel syndrome
por: Li, Pingping, et al.
Publicado: (2020)

Colonization of Clostridium butyricum in Rats and Its Effect on Intestinal Microbial Composition
por: Luo, Xianshu, et al.
Publicado: (2021)

Golden bifid might improve diarrhea-predominant irritable bowel syndrome via microbiota modulation
por: Luo, Mei, et al.
Publicado: (2022)

Molecular characterization, developmental expression, and modulation of occludin by early intervention with Clostridium butyricum in Muscovy ducks
por: Lyu, Wentao, et al.
Publicado: (2021)

Clostridium butyricum and Bifidobacterium pseudolongum Attenuate the Development of Cardiac Fibrosis in Mice
por: Wang, Jiaqi, et al.
Publicado: (2022)

Draft Genome Sequence of Clostridium butyricum Strain NOR 33234, Isolated from an Elderly Patient with Diarrhea
por: Kwok, Jamie S. L., et al.
Publicado: (2014)

Clostridium butyricum relieve the visceral hypersensitivity in mice induced by Citrobacter rodentium infection with chronic stress
por: Wang, Tengfei, et al.
Publicado: (2021)

Clostridium butyricum inhibits epithelial–mesenchymal transition of intestinal carcinogenesis through downregulating METTL3
por: Zhang, Kexin, et al.
Publicado: (2023)

Modulation of inflammation by toll-like receptor 4/nuclear factor-kappa B in diarrhea-predominant irritable bowel syndrome
por: He, Xing, et al.
Publicado: (2017)

Effect of Korean Herbal Medicine Combined with a Probiotic Mixture on Diarrhea-Dominant Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled Trial
por: Ko, Seok-Jae, et al.
Publicado: (2013)

Increased Ileal Immunoglobulin A Production and Immunoglobulin A-Coated Bacteria in Diarrhea-Predominant Irritable Bowel Syndrome
por: Liu, Yi, et al.
Publicado: (2020)

Epidemiology of Functional Diarrhea and Comparison with Diarrhea-Predominant Irritable Bowel Syndrome: A Population-Based Survey in China
por: Zhao, Yan-Fang, et al.
Publicado: (2012)

Metabolism, morphology and transcriptome analysis of oscillatory behavior of Clostridium butyricum during long-term continuous fermentation for 1,3-propanediol production
por: Zhou, Jin-Jie, et al.
Publicado: (2020)

Aberrant Intraregional Brain Activity and Functional Connectivity in Patients With Diarrhea-Predominant Irritable Bowel Syndrome
por: Chen, Xiao-Fei, et al.
Publicado: (2021)

Effects of Clostridium butyricum on Growth Performance, Gut Microbiota and Intestinal Barrier Function of Broilers
por: Li, Wenjia, et al.
Publicado: (2021)

Outbreak of suspected Clostridium butyricum botulism in India.
por: Chaudhry, R, et al.
Publicado: (1998)

Gut Microbiota-Bile Acid Crosstalk in Diarrhea-Irritable Bowel Syndrome
por: Zhan, Kai, et al.
Publicado: (2020)

Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome
por: Wang, Zhe, et al.
Publicado: (2019)

Electroacupuncture for patients with diarrhea-predominant irritable bowel syndrome or functional diarrhea: A randomized controlled trial
por: Zheng, Hui, et al.
Publicado: (2016)

Ramosetron for the treatment of irritable bowel syndrome with diarrhea: a systematic review and meta-analysis of randomized controlled trials
por: Qi, Qingqing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3tr8674i6js2g6eavc7s54uv8b